What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the price band for Metropolis Healthcare Limited IPO?

The price band for Metropolis Healthcare Limited IPO is set at ₹877 to ₹880 per equity share with a minimum lot size of 17 shares.

When does Metropolis Healthcare Limited IPO open and close?

The Metropolis Healthcare Limited IPO opens on 2019-04-03 and closes on 2019-04-05. The allotment date is 2019-04-10 and the listing date is 2019-04-15.

What is the current GMP of Metropolis Healthcare Limited IPO?

The current grey market premium (GMP) for Metropolis Healthcare Limited IPO is ₹0, implying an estimated listing price of ₹880 (0% gain over the upper price band).

How do I check Metropolis Healthcare Limited IPO allotment status?

You can check the allotment status on the registrar's official portal (Link Intime India Private Ltd) or through the BSE/NSE allotment websites once the basis of allotment is finalized.

Metropolis Healthcare Limited

ListedMainboard

Healthcare · NSE / BSE

Incorporated in 1980, Mumbai-based Metropolis Healthcare Limited is a chain of diagnostic companies operating 106 clinical laboratories and 1,130 collection centers across seven countries, with a presence in 18 states and 173 cities in India for disease monitoring, early detection, and diagnostic screening. The company offers 3,480 clinical laboratory tests and 524 profiles, combining various tests for specific diseases, and serves around 7.7 million patients annually, conducting approximately 16 million tests. It also provides analytical and support services for clinical research projects and follows a 'hub and spoke' model to enhance service delivery. Internationally, Metropolis has laboratory operations in Ghana, Zambia, Kenya, Sri Lanka, and Mauritius, and offers third-party services in UAE, Nepal, Nigeria, and Oman. The company has been recognized for excellence in customer service and delivery by Biotrains, for service excellence by FICCI, and as "best in health and fitness" by LH Insights in 2018.

Price Band

₹877 – ₹880

Issue Size

₹1204 Cr

Lot Size

17 shares

GMP

—

Est. Listing

₹880

at current GMP

Subscribed

—

Open

3 Apr 2019

5 Apr 2019

Allotment

10 Apr 2019

Refund

11 Apr 2019

Demat Credit

12 Apr 2019

Listing

15 Apr 2019

Last updated 12 days ago

Overview GMP Subscription Financials IPO Details Company Promoters Objects Peers Documents Allotment FAQs

Key Highlights

•Leading player in the Healthcare segment
•Price band established at ₹877 - ₹880 per equity share
•Minimum bid lot is 17 shares
•Estimated listing target of ₹880 based on current grey market activity